Global Patient Recruitment Program for a Rare Kidney Disease
SubjectWell’s success in a rare disease, phase III Autosomal Dominant Polycystic Kidney Disease (ADPKD) clinical study.
Therapeutic Area: Nephrology
SubjectWell’s success in a rare disease, phase III Autosomal Dominant Polycystic Kidney Disease (ADPKD) clinical study.
®2026 SubjectWell. All rights reserved.
